Effect of preventive treatment on health–related quality of life in episodic migraine

Overview of attention for article published in The Journal of Headache and Pain, August 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 51 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

CHRONIC NIGHTLY DOSING OF LASMIDITAN FOR MIGRAINE PREVENTION

Application EP-4279132-A2

European Patent Office

CHRONIC NIGHTLY DOSING OF LASMIDITAN FOR MIGRAINE PREVENTION

Application WO-2020051137-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.